Stocks and Investing Stocks and Investing
Tue, April 17, 2018
[ 12:00 AM ] - WOPRAI
David Chiaverini Maintained (WTFC) at Buy with Increased Target to $100 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Carlos De Alba Maintained (X) at Buy with Increased Target to $44 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Christine Cho Maintained (WMB) at Hold with Decreased Target to $31 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Evan Kurtz Maintained (STLD) at Hold with Increased Target to $50 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Christine Cho Maintained (AM) at Buy with Decreased Target to $36 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Steven Forbes Initiated (AZO) at Hold on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Dave Kang Upgraded (AXTI) to Strong Buy on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (BAC) at Hold with Increased Target to $37 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
David Leiker Maintained (APTV) at Buy with Increased Target to $107 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Brian Johnson Maintained (APTV) at Buy with Decreased Target to $113 on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Ali Faghri Initiated (AAP) at Strong Buy on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Ali Faghri Initiated (AN) at Hold on, Apr 17th, 2018
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (CBSH) at Sell with Increased Target to $44 on, Apr 17th, 2018
Mon, April 16, 2018
[ 12:00 AM ] - WOPRAI
Steven Valiquette Maintained (CAH) at Hold with Decreased Target to $68 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Rajeev Lalwani Maintained (ALK) at Buy with Increased Target to $79 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Kevin Crissey Maintained (ALK) at Hold with Increased Target to $70 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Jeff Osborne Initiated (VC) at Buy and Held Target at $136 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Sell with Increased Target to $57 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Buy with Increased Target to $73 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Rajeev Lalwani Maintained (BA) at Hold with Increased Target to $400 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Gregory Zhao Maintained (BIDU) at Hold with Increased Target to $260 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Geydar Mamedov Upgraded (BHP) to Strong Buy on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Laura Champine Downgraded (TPX) to Strong Sell and Decreased Target to $9 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (SR) at Sell with Increased Target to $72 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
John Glass Maintained (WING) at Buy with Increased Target to $52 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
James Mitchell Maintained (WFC) at Strong Buy with Decreased Target to $70 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (WFC) at Buy with Decreased Target to $66 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (WFC) at Sell with Decreased Target to $60 on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
Steven Forbes Upgraded (ULTA) to Strong Buy on, Apr 16th, 2018
[ 12:00 AM ] - WOPRAI
David Nierengarten Maintained (BPMC) at Buy with Increased Target to $106 on, Apr 16th, 2018

David Nierengarten Maintained (BPMC) at Buy with Increased Target to $106 on, Apr 16th, 2018


Published on 2024-10-26 04:33:12 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $98 to $106 on, Apr 16th, 2018.

David, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources